Completed PHASE4 INTERVENTIONAL NCT00522158

Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition

Sponsor: Baskent University

Conditions Cardiovascular Disease Cognition LDL Cholesterol Type 2 Diabetes Mellitus

Updated 5 times since 2017 Last updated: Aug 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00522158, this PHASE4 trial focuses on Cardiovascular Disease and Cognition and remains completed. Sponsored by Baskent University, it has been updated 5 times since 2026, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baskent University

Data source: Baskent University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.